Abecma 300000000 1/1
idecabtagene vicleucel · SUSPENSION · Celgene Corporation
No Recall History
Plain English
Abecma is a suspension containing idecabtagene vicleucel at 300000000 1/1, taken intravenous. Manufactured by Celgene Corporation.
Key Facts
- Brand Name
- Abecma
- Generic Name
- idecabtagene vicleucel
- NDC Code (Product)
59572-515- Manufacturer
- Celgene Corporation
- Strength
- 300000000 1/1
- Dosage Form
- SUSPENSION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125736
- Marketing Start
- 03/26/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Abecma used for?
Abecma contains idecabtagene vicleucel. It is a suspension taken intravenous. Consult your doctor for specific uses.
Is Abecma a controlled substance?
Abecma is not classified as a controlled substance by the DEA.
What is the generic name for Abecma?
The generic name for Abecma is idecabtagene vicleucel. There are no other listed brand versions of idecabtagene vicleucel.
What is the NDC code for Abecma 300000000 1/1?
The NDC (National Drug Code) for Abecma 300000000 1/1 is 59572-515, listed by Celgene Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)